Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,199

Document Document Title
WO/2019/173772A1
The present disclosure is directed to l-(2-hydroxy-4-methylcyclohexyl)-ethanone derivatives having unique and desired flavor and/or fragrance characteristics, as well as the synthesis and application of the derivatives. The compounds of ...  
WO/2019/170538A1
The present invention relates to a method for producing an isomer-enriched mixture of 3S- and 3R-caranon of 3-caran epoxide, a 3S-caranon obtained therefrom, a method for producing 3S-caranlactam from 3-carene, a method for producing 3R-...  
WO/2019/173776A1
The present disclosure is directed to 1-(4-methyl cyclohex-1-en-1-yl)ethan-1-one derivatives having unique and desired flavor and/or fragrance characteristics, as well as the synthesis and application of the derivatives. The compounds of...  
WO/2019/166578A1
The present invention relates to the field of catalytic hydrogenation and to the use of ruthenium complexes having a bidentate diphosphine ligand or two monodentate phosphine ligands, two carboxylate ligands and optionally a diamine liga...  
WO/2019/155169A1
The present invention relates to difunctional biphenyl compounds according to formula (I): in which Alk, Alk' and R are as defined in the description. Said compounds are suitable for use as curing agents for thermosetting resins, particu...  
WO/2019/142952A1
Disclosed are a photoactive agent, a method for manufacturing the photoactive agent, and a method for manufacturing a liquid crystal aligning agent, wherein the photoactive agent has a N-O-C=O-C band and is mixed with a liquid crystal al...  
WO/2019/138323A1
This invention relates to compounds of formula 1, 2 or 3, Formulae (1), (2), (3), a pharmaceutically acceptable salt, or a solvate thereof, wherein X1, Y, R1, R2, R3, R4, and R5 are as defined herein. The compounds are antimicrobial agen...  
WO/2019/132739A1
The present invention relates to the field of organic chemistry and pharmacology and describes novel asymmetric derivatives of polyphenols of the dinaphthalene series of general Formula (I) or general Formula (II), a process of preparing...  
WO/2019/129815A1
The invention provides a method for synthesizing a compound of formula (I) wherein each R independently represents an optionally substituted aryl, heteroaryl, alkyl, perfluoroalkyl, cycloalkyl, alkoxy, aryloxy, acyl, carboxyl, hydroxyl, ...  
WO/2019/122204A1
Disclosed are processes for the manufacture of pyrazole compounds of formula (I) and their application in the manufacture of pyrazole derivatives, in particular in processes for the manufacture of pharmaceutically or agrochemically activ...  
WO/2019/122164A1
The present invention concerns processes for the manufacture of pyrazole carboxylic derivatives and precursors thereof.  
WO/2019/117262A1
The present invention provides a composition for promoting cell adhesion containing a compound represented by general formula (I) or a salt thereof. {In the formula, each symbol is as defined in the description.}  
WO/2019/117255A1
The present invention addresses the problem of providing an industrially preferable, economical, and environmentally friendly method for producing the 4,5-dihydroisoxazole represented by a formula (3). The present invention enables the c...  
WO/2019/104888A1
Disclosed is an imine-type quaternary ammonium salt catalyst, wherein the catalyst has a general structure formula shown by formula I below; in the formula, R1 and R2, respectively, are independently selected from C1-C20 linear alkyl or ...  
WO/2019/096209A1
Provided are a chiral 1,3-diarylimidazolium salt carbene precursor (S), a synthesis method therefor, a metal salt compound, and an application thereof. The chiral 1,3-diarylimidazolium salt carbene precursor catalyzes a reaction between ...  
WO/2019/099371A1
Provided herein are compounds that are prodrugs for mesalazine. Generally, the compounds described herein correspond to a mesalazine molecule wherein the amino group is replaced by a novel protecting group. For example, in the compounds ...  
WO/2019/087985A1
The purpose of the present invention is to obtain: a cured film that has high sensitivity, enables formation of a pattern of a low-tapered shape after development, is capable of suppressing a change in the dimensional width of pattern op...  
WO/2019/036349A8
This invention discloses the first example of palladium(ll)-catalyzed β-C(sp3)-H iodination or arylation of a wide range of ketones by using a commercially available aminooxyacetic acid auxiliary. This L, X-type directing group overcome...  
WO/2019/084476A1
This disclosure relates to small molecule inhibitors of Fibroblast growth factor 23 (FGF-23) and related compositions and methods of treatment.  
WO/2019/076926A1
The present invention relates to new classes of odorous oximes and their ketone intermediates (odorants) which are useful as fragrance or flavor materials in particular in providing cassis, catty, tropical, green, coniferous, thuya, flor...  
WO/2019/071110A1
Glutamine antagonists and their use for treating oncological, immunological, and neurological diseases are disclosed. Also disclosed are methods for treating an oncological, immunological, infectious or neurological disease or disorder, ...  
WO/2019/047846A1
Derivatives of hypocrellin with peri-position and 2-position simultaneously substituted by amino groups and a preparation method and application thereof are disclosed. The structural formula of the derivatives is as shown in the formulae...  
WO/2019/040463A1
Provided are novel compounds of Formulas (I) and (II), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful as dual FKBP12/FKABP inhibitors. Also provided are pharmaceutical compositions co...  
WO/2019/036349A1
This invention discloses the first example of palladium(ll)-catalyzed β-C(sp3)-H iodination or arylation of a wide range of ketones by using a commercially available aminooxyacetic acid auxiliary. This L, X-type directing group overcome...  
WO/2019/022222A1
The present invention provides an additive composition for a culture medium, the composition containing a compound represented by formula (I) or a salt thereof. (In the formula, each symbol is as defined in the description.)  
WO/2019/013112A1
An oxime ester compound represented by general formula (I). (In the formula, at least three moieties among R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 moieties are groups represented by general formula (II); and it is prefe...  
WO/2018/235530A1
The present invention provides a metal alkoxide compound represented by general formula (1) (in the formula: R1 and R2 each independently denote an alkyl group having 1-4 carbon atoms; R3 denotes an alkyl group having 2 or 3 carbon atoms...  
WO/2018/232298A1
The present invention provides a compound having the structure: and use of the compound for inhibiting the growth of or killing a fungus  
WO/2018/228981A1
The invention relates to a process for the preparation of a compound represented by formula (I) wherein X is selected from the group consisting of -H, -halogen, linear or branched C1-C7 alkyl group, linear or branched C1-C5 alkoxy group,...  
WO/2018/228857A1
The invention relates to novel laser markable compositions comprising developing agent precursors according to formula (I).  
WO/2018/226374A1
Antidegradant compounds are disclosed, and methods of making them, that are represented by the formula (I), wherein each X is independently selected from the group consisting of ethyl, methyl, or hydrogen. Also disclosed are diimine inte...  
WO/2018/199146A1
Provided is a novel method for producing amide compounds at high stereochemical selectivity. This method for producing amide compounds is provided with an amidation step for reacting an aminoester compound represented by general formula ...  
WO/2018/196619A1
Disclosed are a fluorene oxime ester photoinitiator containing a polymerizable group, a preparation method and the use thereof, the fluorene oxime ester photoinitiator has the structure as shown in general formula (I), wherein R2 represe...  
WO/2018/187479A1
A method of modulating ribonucleotide reductase activity in a neoplastic cell includes administering to the cell an amount of a triazole or an oxadiazole ribonucleotide reductase modulator (RRmod), the amount being effective to inhibit n...  
WO/2018/184933A1
It is described an industrially viable and advantageous process for the preparation of racemic beta-aminosulfone (1), an useful intermediate for the preparation of N-(2-((1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)et hyl)-2,3-dih...  
WO/2018/166505A1
Disclosed are a compound represented by formula I or a pharmaceutically acceptable salt thereof, a preparation method therefor, and an application thereof in preventing or treating fatty liver or in preparing weight-reducing drugs.  
WO/2018/157617A1
Disclosed is a process method for the synthesis of a ketoxime. The method comprises reacting a ketone and ammonia with hydrogen peroxide to obtain a ketoxime with a titanium silicon zeolite as a catalyst in an aqueous carbonate solution ...  
WO/2018/159505A1
Provided are: a dissimilar-metal salt assembly which is a dendrimer capable of having a large number of, i.e., four or more types, particularly five or more types of dissimilar-metal salt compounds having dissimilar metals precisely inte...  
WO/2018/154344A1
The compounds with the general formula (I) are disclosed where n1 is the number of carbon atoms connected to nitrogen atom by a double bond and can take on values between 25 and 41, and where n2 is the number of -CH2- groups and can take...  
WO/2018/139485A1
The present invention addresses the problem of providing a dichloroglyoxime production method by which dichloroglyoxime, which can be used as an industrial anti-bacterial agent, a preservative, a slime control agent or the like, can be o...  
WO/2018/140987A1
This patent mentioned the synthesis of new metal-organic framework based on hexameric titanium-oxo cluster. The novel material, termed MOF-902, was successfully synthesized and its crystal structure uncovered the 2-Dimensional (2D) layer...  
WO/2018/134757A1
Oxo-nitrogenated iron complex having general formula (I): in which: R1 and R2, identical or different, represent a hydrogen atom; or they are selected from linear or branched, optionally halogenated C1 - C20, preferably C1-C15, alkyl gro...  
WO/2018/135395A1
An electrolytic solution for non-aqueous secondary batteries, which comprises an electrolyte, an organic solvent and a metal complex represented by general formula (I); a non-aqueous secondary battery using the electrolytic solution for ...  
WO/2018/134410A1
The present invention relates to the field of perfumery and flavor. More particularly, it concerns cleavable surfactants of formula (I) having a total hydrophilic-lipophilic balance (HLB) comprised between 3 and 18 and wherein A is a gro...  
WO/2018/132766A1
The invention relates to methods, systems and kits for determining therapeutic effectiveness or toxicity of cancer-treating compounds that incorporate into or bind to DNA. In particular, the invention is directed to methods, systems and ...  
WO/2018/128084A1
Provided is a polymerizable compound that has low-wavelength dispersion or reverse-wavelength dispersion, does not readily bubble when made into a coating material, has excellent substrate adhesion when made into a film-like polymer, and...  
WO/2018/116158A1
The present invention relates to new compounds having hydroxyl, imino and carboxylic functionalities, processes for the production thereof and use thereof as antitumour agents for the treatment of solid tumours.  
WO/2018/102427A1
Provided herein are methods of preparation of I by reacting i with acid where R1 and R2 are each independently a leaving group. Intermediates to make i are also claimed.  
WO/2018/088436A1
Disclosed is an ammoximation catalyst useful in producing oximes from ketones with high yield and high selectivity by ammoximation reaction using hydrogen, oxygen and ammonia. The ammoximation catalyst contains (a) a titanosilicate and (...  
WO/2018/085753A1
Provided herein are substituted hydrazone compounds useful as inhibitors of DEPTOR. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted hyd...  

Matches 1 - 50 out of 7,199